Patients with peripheral neuropathy have symptoms involving small-diameter nociceptive nerves and elevated thermal thresholds. Nociceptive nerves terminate in the epidermis of the skin and are readily demonstrated with the neuronal marker, protein gene product 9.5 (PGP 9.5). To investigate the pathological characteristics of elevated thermal thresholds, we performed PGP 9.5 immunocytochemistry on 3 mm punch skin biopsies (the forearm and the leg) from 55 normal subjects and 35 neuropathic patients. Skin innervation was evaluated by quantifying epidermal nerve densities. Epidermal nerve densities were reduced in neuropathic patients compared to normal subjects. Epidermal nerve densities were variably correlated with thermal thresholds. The proportion of neuropathic patients with reduced epidermal nerve densities was larger than the proportion of neuropathic patients with elevated thermal thresholds. These results indicated that degeneration of epidermal nerve terminals preceded the elevation of thermal thresholds. Skin biopsy together with immunocytochemical demonstration of epidermal innervation offers a new approach to evaluate small-®ber sensory neuropathy. NeuroReport
INTRODUCTION
Patients with peripheral neuropathy frequently have sensory symptoms involving small-diameter nociceptive nerves. Because no neurophysiological test is clinically feasible for evaluating nociceptive nerves, quantitative sensory testing is the only tool for examining small-®ber sensory neuropathy at present [1] . Quantitative sensory testing measures the thresholds of various sensory modalities, including warm and cold stimuli [2±4] . Thermal sensations are conducted by small-diameter sensory nerves, which terminate in the epidermis of the skin, free nerve endings [5] . The extent of sensory de®cits can be quanti®ed according to changes in sensory thresholds compared to normative data. Thermal thresholds are altered in various types of neuropathies [6, 7] . However, it remains unclear whether elevation of thermal threshold really re¯ects degeneration of small-diameter sensory nerves.
Pathological diagnosis of small-®ber sensory neuropathy has been a challenge to neurologists. Traditional evaluation of nerve biopsy specimens is a labor-intensive procedure because of the requirement for ultrastructural studies by electron microscopy. Small-diameter nociceptive nerves terminate in the epidermis of the skin as free nerve endings. Recently several groups including ours have demonstrated the rich innervation of the skin by immunocytochemistry with various neuronal markers, including protein gene product 9.5 (PGP 9.5) [8±11]. PGP 9.5, a ubiquitin carboxy hydrolase, is particularly enriched in small-diameter nerves [12] . Epidermal nerve terminals are depleted when nerve trunks are injured in Wallerian degeneration [13] .
A critical issue is whether epidermal nerves degenerate in neuropathies patients with sensory symptoms, i.e. is epidermal innervation correlated with thermal thresholds? If so, what kinds of sensory modalities are best correlated with epidermal nerve densities? To address these issues, we compared epidermal nerve densities and thermal threshold of normal subjects and neuropathic patients.
MATERIALS AND METHODS
Normal subjects and neuropathic patients: Normal subjects were recruited from a cohort in the community and those visiting National Taiwan University Hospital, Taipei, Taiwan for a physical check-up [14] . They were evaluated by detailed questionnaires and neurological examinations to exclude any neurological disorder or clinical neuropathies [15] . Examinations consisted of laboratory tests (complete blood count, fasting blood glucose, hemoglobin A 1C , liver and renal functions, serum protein electrophoresis, anti-nuclear antibody, and vitamin B 12 level), nerve conduction studies, and quantitative sensory testing. There were 55 normal subjects (19 males and 36 females) aged 45.94 AE 12.95 years (range 26±82).
Neuropathic patients were regularly followed-up at the Department of Neurology. They all had symmetrical sensory symptoms of the glove±stocking distribution in the upper and lower extremities. The neuropathy group consisted of 35 patients (17 males and 18 females) aged 47.3 AE 11.6 years (range 25±73). These patients had progressive sensory polyneuropathy. Nerve conduction studies showed reduction of sural sensory action potentials. Thus these patients all had neuropathy involving large-diameter nerves, and potentially had de®cits of small-diameter sensory nerves. Seven patients underwent nerve biopsy and unmyelinated nerve densities were reduced. The etiologies included diabetes mellitus (5), vasculitis (2) and idiopathic neuropathy in the rest. The protocol was approved by the Institutional Review Board of National Taiwan University Hospital. Informed consent was signed before all biopsies.
Skin biopsy: Skin biopsy was performed following established procedures after local anesthesia with 2% lidocaine [15] . Punches 3 mm in diameter were taken from each site: (1) the forearm site: the extensor side of the distal forearm, 5 cm above the middle point of the line connecting the radial styloid process and the ulnar styloid process, and (2) the leg site: the lateral side of the distal leg, 10 cm above the lateral malleolus. All healthy controls and neuropathic patients had skin biopsies at both sites. All subjects tolerated the procedure with no obvious discomfort. No suturing was required, and the wounds were covered with a piece of gauze. Wound healing took 7±10 days, the same as a common abrasion wound.
Immunocytochemistry: For immunocytochemistry on freezing microtome sections, the skin tissues were ®xed with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB) for 48 h [16] . After thorough rinsing in PB, samples were cryoprotected with 30% sucrose in PB overnight. Sections of 50 ìm perpendicular to the dermis were cut on a sliding microtome (Microm 440E, Microm, Germany). Sections from each tissue were labeled sequentially and stored with antifreeze (30% glycerol, 30% ethylene glycol in PB) at À208C. Sections were treated with 0.5% Triton X-100 in 0.5 M Tris buffer, pH 7.6 (Tris) for 30 min and processed for immunostaining. Sections were quenched with 1% H 2 O 2 in methanol, and blocked with 5% normal goat serum in 0.5% non-fat dry milk/Tris. Sections were incubated with rabbit antiserum to PGP 9.5 (UltraClone, UK, diluted 1: 1000 in 1% normal serum/Tris) for 16±24 h. After rinsing in Tris, sections were incubated with biotinylated goat anti-rabbit IgG for 1 h, and the avidin±biotin complex (Vector, Burlingame, CA) for another hour. The reaction product was demonstrated by the chromogen SG (Vector, Burlingame, CA), and counterstained with eosin (Sigma, St. Louis, MO).
Quantitation of epidermal innervation: Epidermal innervation was quanti®ed according to modi®ed protocols in a coded fashion, with the examiners blinded to the coded information [11] . PGP 9.5 () nerves in the epidermis of each section were counted at a magni®cation of 340 with an Olympus BX40 microscope (Shibuya-ku, Japan). Each individual nerve with branching points inside the epidermis was counted as one. For epidermal nerves with branching points in the dermis, each individual nerve was counted separately. The length of the epidermis along the upper margin of the stratum corneum in each section was measured with the Image-Pro PLUS (Media Cybernetics, Silver Spring, MD). Epidermal nerve density was therefore derived and expressed as the number of epidermal nerves per unit length of the epidermis (®bers/mm). For each tissue, there were 48±50 sections after sectioning, and all sections were sequentially labeled. Based on preliminary results of staining and quantifying all sections, the standard procedures were to immunostain and quantify the 13th, 19th, 25th, 31st, and 37th sections of each tissue. The mean of epidermal nerve densities on these sections was the epidermal nerve density of that tissue.
Quantitative sensory testing: Thermal sensory thresholds were measured by quantitative sensory testing with a Thermal Sensory Analyzer, TSA-2001 (Medoc Advanced Medical System, Minneapolis, MN) following established principles and protocols [17] . Testing modalities included warm sensation and cold sensation with the testing algorithms of level, which was independent of reaction time [1] . Thermal thresholds at the thenar area (the hand site) and the foot dorsum (the foot site) were measured. The procedures were carried out in a quiet room at a room temperature of 21±248C. Skin temperatures were 31±348C under such an environment. During the examination, the reference temperature was set at 328C, and the temperature went up (warm stimuli) or went down (cold stimuli) according to the default algorithms. Normative data were generated previously in different cohorts, and there was no signi®cant ethnic difference [18] .
Statistical analysis: Epidermal nerve densities in the control group and in the neuropathy group were expressed as the mean AE s.d., and were compared by t-test after the normality of distribution was con®rmed. Correlations between epidermal nerve densities and sensory thresholds were evaluated by linear regression analysis with SPSS for Windows (ver 6.1, SPSS, Chicago, IL) and GraphPad Prism (ver 2.01, GraphPad Software, San Diego, CA). The 95% con®dence interval (95% CI) of Pearson's coef®cient was included. Sensitivity and speci®city were calculated based on the ®fth percentile value as the cut-off point. Any difference with p , 0.05 was considered statistically signi®-cant.
RESULTS
Skin innervation in small-®ber sensory neuropathy: In the leg skin of normal subjects, PGP 9.5() nerves arose from the dermis, subepidermal nerve plexuses, and ascended vertically in the epidermis (Fig. 1a) . In the dermis, PGP 9.5() dermal nerves were occasionally in groups with a dense and continuous pattern of staining (Fig. 1) . In patients with sensory neuropathy, the abundance of PGP 9.5() was reduced, and the staining in the subepidermal nerve plexuses became faint and discontinuous (Fig. 1b) . The immunoreactive pattern of dermal nerves in neuropathic patients became fragmented and swollen, re¯ecting Wallerian-like degeneration (Fig. 1d) .
Quantitative characteristics of epidermal innervation:
Epidermal nerve densities were reduced in neuropathic patients, particularly in the distal leg. Epidermal nerve densities of the distal forearm were 17.360 AE 6.194 ®bers/ mm in normal subjects. In neuropathic patients, epidermal nerve densities of the distal forearm were reduced to 5.631 AE 4.955 ®bers/mm ( p , 0.001, Fig. 2a ). In the distal leg of normal subjects, epidermal nerve densities were 12.970 AE 5.284 ®bers/mm, and these values were 2.160 AE 2.185 ®bers/mm at the same site of neuropathic patients ( p , 0.001, Fig. 2a) .
In normal subjects, epidermal nerve densities in the forearm and leg were correlated (slope 0.916 AE 0.111, r 0.75, p , 0.0001, Fig. 2b) . Densities in the forearm were signi®cantly higher than those in the leg (Y-intercept: 5.720 AE 1.535 ®bers/mm, p , 0.001). In neuropathic patients, the loss of epidermal nerves in the forearms and in the legs was variable, which re¯ected the pathophysiology of different underlying neuropathies.
The ratios of epidermal nerve densities (the forearm vs the leg) were 1.488 AE 0.569 (95% CI: 1.328, 1.647) in normal subjects and were independent of age ( p 0.86, Fig. 2c ).
These ratios were signi®cantly elevated in neuropathic patients compared to normal subjects (3.670 AE 4.532, p , 0.002), re¯ecting the nature of length-dependency.
Epidermal nerve densities and sensory thresholds:
The correlations between epidermal nerve densities and sensory thresholds at the same site were evaluated by linear regression analysis. In normal subjects and neuropathic patients, correlations between epidermal nerve densities and sensory thresholds varied among different sites and different modalities (Fig. 3) . Epidermal nerve densities were better correlated with warm thresholds than with cold thresholds. For example, correlations between epidermal nerve densities of the distal leg and warm thresholds of the foot dorsum (r 0.483; 95% CI: À0.6819, À0.2168, p , 0.001) were higher than those between epidermal nerve densities and cold thresholds of the foot (r 0.381, 95% CI: 0.094, 0.609, p , 0.01) in normal subjects. The correlations were more obvious in the neuropathy group than in the control group, e.g. the correlation coef®cient for epidermal nerve densities and warm thresholds in the foot dorsum were À0.483 (95% CI: À0.6819, À0.2168) in the control group and À0.705 (95% CI: À0.8713, À0.3922) in the neuropathy group. The proportion of neuropathic patients with reduced epidermal nerve densities was larger than the proportion of neuropathic patients with elevated thermal thresholds ( Table 1) .
DISCUSSION
This report provides rationales for using skin biopsy and quantitative sensory testing in clinical practice. In neuropathic patients, epidermal nerve density was reduced and the immunoreactive patterns of dermal nerves become fragmented. These provide objective and quanti®able parameters for evaluation of small-diameter sensory nerve degeneration.
Skin innervation in small-®ber sensory neuropathy: The 3 mm punch skin biopsy is a simple procedure with minimal invasiveness, and provides ample information regarding the pathological basis of small-®ber neuropathy. Epidermal innervation is reduced in small-®ber neuropathy, particularly in the lower extremities, consistent with the notion of length-dependent neuropathy. These pathological changes are correlated with changes in sensory thresholds, and probably preceded the elevation of sensory thresholds. This carries an important implication that evaluation of epidermal innervation is feasible as a clinical diagnostic parameter.
Nerve terminals are particularly vulnerable in toxic and mechanical damage to nerves of various types [19] . Epidermal nerves are depleted within 24±48 h after nerve transec- tion in rodents. At that time point, the organization of nerve trunks remains normal [11] . Degenerating motor nerve terminals become swollen before the degeneration of motor nerve trunks in acrylamide intoxication [19] . The mechanisms of early degeneration in nerve terminals remain largely unknown. Calcium in¯ux and free radicals contribute to the process [20] . All these suggest the early degeneration of nerve terminals, and offer a rationale for examining epidermal nerve terminals in small-®ber sensory neuropathy [21, 22] .
Diagnostic approaches to small-®ber sensory neuropathy: Evaluation of epidermal innervation by skin biopsy offers pathological evidence of nerve degeneration at the level of nociceptive terminals. Traditional evaluation of small-®ber sensory neuropathy relies entirely on measurements of various psychophysical tests, for example, sensory thresholds and current perception thresholds [23] . Thresholds of warm sensation, cold sensation, and current perception are elevated in diabetic neuropathy, uremic neuropathy, and various hereditary sensory neuropathies [24] . Quantitative sensory testing is particularly useful for series follow-up of clinical progression and therapeutic responses, as well as group comparison in ®eld studies [24] . An important drawback of quantitative sensory testing is its dependence on the attention and cooperation of subjects [1] . There are physiological alternatives for measuring the conduction of smalldiameter sensory nerves, such as with laser-evoked stimulation [25] . However, the discomfort caused by stimulating nociceptive nerves precludes large-scale clinical applications. Studies by laser-evoked stimulation of nociceptive nerves are mainly restricted to research purpose. 
CONCLUSION
Skin biopsy and quantitative sensory testing are complementary for evaluation of small-diameter sensory nerve functions. The elevation of sensory thresholds can be caused by disorders of the central or peripheral nervous systems, for example, the elevation of sensory thresholds in a diabetic patient with a history of stroke. Quantitative sensory testing, with the advantage of simplicity and noninvasiveness, provides no information regarding anatomical localization. Skin biopsy, on the other hand, can assess the pathological substrate of elevated sensory thresholds [21, 22] . The present study proposes that both skin biopsy and quantitative sensory testing should be an integrated package for examining small-®ber sensory neuropathy. 
